文献速递复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

非心脏病类疾病患儿院内心脏骤停体外心肺复苏的结局

Outcomes of Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest Among Children With Noncardiac Illness Categories.
PubMed 文献 · Crit Care Med · 2023-12-29
一句话结论非心脏病类疾病患儿院内心脏骤停接受ECPR与常规CPR的出院存活率无显著差异(21.4% vs 16.2%,校正OR 1.42,95%CI 0.84-2.40,P=0.19),贝叶斯分析提示可能存在生存获益(后验概率85.1%)。

该回顾性多中心队列研究纳入2000至2021年美国心脏协会Get With The Guidelines-Resuscitation登记库中875例非心脏病类疾病、接受≥30分钟CPR的院内心脏骤停患儿(<18岁),其中159例接受ECPR、716例接受常规CPR。倾向评分加权多变量logistic回归未发现ECPR与出院存活率之间存在显著关联(校正OR 1.42,95%CI 0.84-2.40,P=0.19);单因素分析中ECPR组出院存活率21.4% vs 常规CPR组16.2%(P=0.13)。贝叶斯模型估计ECPR对出院存活率产生正效应的后验概率为85.1%。20年间ECPR使用率显著增加(P<0.001)。

要点

  • 在非心脏病类疾病院内心脏骤停患儿中,ECPR组出院存活率21.4% vs 常规CPR组16.2%,单因素分析P=0.13,差异未达统计学显著。
  • 倾向评分加权多变量logistic回归显示,ECPR与出院存活率无显著关联(校正OR 1.42,95%CI 0.84-2.40,P=0.19)。
  • 贝叶斯logistic回归模型估计ECPR对出院存活率产生正效应的后验概率为85.1%。
  • 2000至2021年间,该人群ECPR使用率显著增加(P<0.001)。
  • 研究人群CPR中位持续时间45(35-63)分钟,68%(597/875)的患儿主要诊断为呼吸功能不全。

适用人群与场景

  • 美国心脏协会Get With The Guidelines-Resuscitation登记库中2000至2021年收录的<18岁非心脏病类疾病患儿,因院内心脏骤停接受≥30分钟心肺复苏。

诊断标准与关键阈值

  • 纳入标准:年龄<18岁、非心脏病类疾病类别、院内心脏骤停、接受≥30分钟心肺复苏。

研究设计与关键结果

  • 研究类型:回顾性多中心队列研究,数据来源为美国心脏协会Get With The Guidelines-Resuscitation登记库(2000至2021年)。
  • 样本量:共875例,其中ECPR组159例、常规CPR组716例;中位年龄1.0(四分位距0.2-7.0)岁;68%(597/875)主要诊断为呼吸功能不全;CPR中位持续时间45(35-63)分钟。
  • 主要终点:出院存活率ECPR组21.4% vs 常规CPR组16.2%,单因素分析P=0.13;倾向评分加权多变量logistic回归校正OR 1.42(95%CI 0.84-2.40,P=0.19)。
  • 贝叶斯分析:ECPR对出院存活率产生正效应的后验概率为85.1%。
  • 时间趋势:ECPR使用率随时间显著增加(P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ECPR与出院存活率之间未发现显著关联,但事后贝叶斯分析提示可能存在生存获益(后验概率85%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The objective of this study was to determine the association of the use of extracorporeal cardiopulmonary resuscitation (ECPR) with survival to hospital discharge in pediatric patients with a noncardiac illness category. A secondary objective was to report on trends in ECPR usage in this population for 20 years.

DESIGN: Retrospective multicenter cohort study.

SETTING: Hospitals contributing data to the American Heart Association's Get With The Guidelines-Resuscitation registry between 2000 and 2021.

PATIENTS: Children (<18 yr) with noncardiac illness category who received greater than or equal to 30 minutes of cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Propensity score weighting balanced ECPR and conventional CPR (CCPR) groups on hospital and patient characteristics. Multivariable logistic regression incorporating these scores tested the association of ECPR with survival to discharge. A Bayesian logistic regression model estimated the probability of a positive effect from ECPR. A secondary analysis explored temporal trends in ECPR utilization. Of 875 patients, 159 received ECPR and 716 received CCPR. The median age was 1.0 [interquartile range: 0.2-7.0] year. Most patients (597/875; 68%) had a primary diagnosis of respiratory insufficiency. Median CPR duration was 45 [35-63] minutes. ECPR use increased over time ( p < 0.001). We did not identify differences in survival to discharge between the ECPR group (21.4%) and the CCPR group (16.2%) in univariable analysis ( p = 0.13) or propensity-weighted multivariable logistic regression (adjusted odds ratio 1.42 [95% CI, 0.84-2.40; p = 0.19]). The Bayesian model estimated an 85.1% posterior probability of a positive effect of ECPR on survival to discharge.

CONCLUSIONS: ECPR usage increased substantially for the last 20 years. We failed to identify a significant association between ECPR and survival to hospital discharge, although a post hoc Bayesian analysis suggested a survival benefit (85% posterior probability).

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Loaec M, Himebauch AS, Reeder R, et al. Outcomes of Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest Among Children With Noncardiac Illness Categories. Crit Care Med. 2023. PMID: 38156912. doi:10.1097/CCM.0000000000006153

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。